Recent centuries have witnessed remarkable advancements in the management of muscular dystrophy. Experts are actively investigating innovative methods that hold potential for enhancing the lives of individuals living with this progressive disease. Drug development have emerged as particularly potent avenues for addressing the underlying mechanisms